Advisor Group Holdings »

Lipocine shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $188 68 2.78
2023-09-30 $201 68 2.96
2023-06-30 $341 68 5.03

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Lipocine

Vanguard Group
Two Sigma Advisers
Caldwell Sutter Capital
Royal Bank of Canada
Advisor Group Holdings
Tidemark
Wells Fargo & Company
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Lipocine